Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia.

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.

Hum Psychopharmacol. 2013 May;28(3):215-9. doi: 10.1002/hup.2309. Epub 2013 Apr 2.

PMID:
23553637
2.

Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.

Hum Psychopharmacol. 2013 Jan;28(1):94-6. doi: 10.1002/hup.2277. Epub 2012 Nov 13.

PMID:
23161621
3.

Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.

Suzuki Y, Sugai T, Ono S, Sawamura K, Fukui N, Watanabe J, Tsuneyama N, Saito M, Someya T.

Psychiatry Clin Neurosci. 2014 May;68(5):353-6. doi: 10.1111/pcn.12136. Epub 2014 Jan 9.

PMID:
24405493
4.

The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone.

Lee NY, Kim SH, Jung DC, Kim EY, Yu HY, Sung KH, Kang UG, Ahn YM, Kim YS.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1273-8. doi: 10.1016/j.pnpbp.2011.03.022. Epub 2011 Apr 14.

PMID:
21513765
5.

Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.

Suzuki Y, Sugai T, Fukui N, Watanabe J, Ono S, Tsuneyama N, Saito M, Someya T.

Schizophr Res. 2013 Apr;145(1-3):116-9. doi: 10.1016/j.schres.2012.12.027. Epub 2013 Jan 31.

PMID:
23375624
6.

A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.

Lee SY, Park MH, Patkar AA, Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):490-6. doi: 10.1016/j.pnpbp.2010.12.003. Epub 2010 Dec 10.

PMID:
21146575
7.

Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.

Watanabe J, Suzuki Y, Fukui N, Ono S, Sugai T, Tsuneyama N, Someya T.

J Clin Psychopharmacol. 2012 Feb;32(1):18-22. doi: 10.1097/JCP.0b013e31823f6f21.

PMID:
22198445
8.
9.

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials.

Stauffer V, Ascher-Svanum H, Liu L, Ball T, Conley R.

BMC Psychiatry. 2009 Mar 31;9:13. doi: 10.1186/1471-244X-9-13.

10.

Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.

Hatta K, Otachi T, Fujita K, Morikawa F, Ito S, Tomiyama H, Abe T, Sudo Y, Takebayashi H, Yamashita T, Katayama S, Nakase R, Shirai Y, Usui C, Nakamura H, Ito H, Hirata T, Sawa Y; JAST study group.

Schizophr Res. 2014 Sep;158(1-3):213-22. doi: 10.1016/j.schres.2014.07.015. Epub 2014 Jul 31.

11.

Switching antipsychotic medications: not enough, too often, or just right?

Weiden PJ.

Am J Psychiatry. 2011 Sep;168(9):882-4. doi: 10.1176/appi.ajp.2011.11060958. No abstract available.

PMID:
21890800
12.

Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis.

Chung AK, Chua SE.

J Psychopharmacol. 2011 May;25(5):646-66. doi: 10.1177/0269881110376685. Epub 2010 Sep 8.

PMID:
20826552
13.

Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.

Lublin H, Haug HJ, Koponen H, Sigmundsson T, Kolb SA.

World J Biol Psychiatry. 2009;10(4 Pt 3):710-8. doi: 10.1080/15622970802269589.

PMID:
18803070
14.

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

Czekalla J, Beasley CM Jr, Dellva MA, Berg PH, Grundy S.

J Clin Psychiatry. 2001 Mar;62(3):191-8.

PMID:
11305706
15.

Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.

Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY.

Psychopharmacology (Berl). 2011 Jul;216(1):9-16. doi: 10.1007/s00213-011-2188-5. Epub 2011 Feb 9.

PMID:
21301815
16.

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK.

JAMA. 2009 Oct 28;302(16):1765-73. doi: 10.1001/jama.2009.1549. Erratum in: JAMA. 2009 Dec 2;302(21):2322.

17.

Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.

Camm AJ, Karayal ON, Meltzer H, Kolluri S, O'Gorman C, Miceli J, Tensfeldt T, Kane JM.

CNS Drugs. 2012 Apr 1;26(4):351-65. doi: 10.2165/11599010-000000000-00000.

PMID:
22452529
18.

Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.

Moons T, Claes S, Martens GJ, Peuskens J, Van Loo KM, Van Schijndel JE, De Hert M, van Winkel R.

Schizophr Res. 2011 Feb;125(2-3):187-93. doi: 10.1016/j.schres.2010.10.008. Epub 2010 Nov 3.

PMID:
21050724
19.

Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.

Moteshafi H, Stip E.

Expert Opin Drug Saf. 2012 Sep;11(5):713-32. doi: 10.1517/14740338.2012.712682.

PMID:
22913713
20.

QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.

Ozeki Y, Fujii K, Kurimoto N, Yamada N, Okawa M, Aoki T, Takahashi J, Ishida N, Horie M, Kunugi H.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):401-5. doi: 10.1016/j.pnpbp.2010.01.008. Epub 2010 Jan 15.

PMID:
20079791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk